EDIT vs VICI
Editas Medicine Inc (EDIT) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
EDIT currently screens at market cap $375.2M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the EDIT and VICI stock pages for the full models.
Not investment advice.